Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences

被引:146
作者
Greenfield, JR
Samaras, K
Jenkins, AB
Kelly, PJ
Spector, TD
Gallimore, JR
Pepys, MB
Campbell, LV
机构
[1] St Vincents Hosp, Ctr Diabet, Darlinghurst, NSW 2010, Australia
[2] St Vincents Hosp, Dept Endocrinol, Darlinghurst, NSW 2010, Australia
[3] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW, Australia
[4] Univ Wollongong, Dept Biomed Sci, Wollongong, NSW 2500, Australia
[5] Orchid Biosci Inc, Princeton, NJ USA
[6] St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London, England
[7] UCL Royal Free & Univ Coll Med Sch, Ctr Amyloidosis & Acute Phase Prot, Dept Med, London, England
关键词
obesity; inflammation; syndrome X; lipids;
D O I
10.1161/01.CIR.0000130640.77501.79
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - C-reactive protein (CRP) values predict atherothrombotic cardiovascular disease and type 2 diabetes mellitus. Associations between CRP and obesity, predominantly assessed anthropometrically, may partly explain these observations. Previous studies have been unable to control for genetic influences on CRP and obesity. The aim of this study was to examine the relationship between CRP and accurately measured body fat, lipids, apolipoproteins, blood pressure, and environmental and behavioral factors, independent of genetic influences. Methods and Results - One hundred ninety-four healthy female twins ( age 57.2 +/- 7 years) were studied after excluding pairs with CRP values > 10 mg/L. Total body fat and central abdominal fat (CAF) were measured by dual-energy x-ray absorptiometry. CRP concentration was strongly related to surrogate and direct measures of body fat ( r = 0.31 to 0.54, P < 0.001), diastolic blood pressure ( r = 0.20, P = 0.003), and lipid and apolipoprotein levels ( r = 0.21 to 0.51, P < 0.008). Light-to-moderate alcohol consumers and nonusers of hormone replacement therapy (HRT) had lower CRP levels than abstainers and HRT users, respectively. In stepwise multiple regression analysis, CAF, triglycerides, apolipoprotein B, and HRT use explained 46% of the variance in circulating CRP. In analyses controlling for genetic influences in monozygotic twins, within-pair differences in CRP were associated with within-pair differences in total body fat ( r = 0.39, P < 0.001), CAF ( r = 0.34, P = 0.002), diastolic blood pressure ( r = 0.24, P = 0.03), apolipoprotein AI ( r = -0.33, P = 0.01), HDL cholesterol ( r = - 0.42, P = 0.001), and triglycerides ( r = 0.35, P = 0.007). Conclusions - CRP was strongly related to total and central abdominal obesity, blood pressure, and lipid levels, independent of genetic influences. These relationships are likely to contribute significantly to prospective associations between CRP and type 2 diabetes and coronary events.
引用
收藏
页码:3022 / 3028
页数:7
相关论文
共 62 条
  • [1] Alcohol consumption and plasma concentration of C-reactive protein
    Albert, MA
    Glynn, RJ
    Ridker, PM
    [J]. CIRCULATION, 2003, 107 (03) : 443 - 447
  • [2] Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women
    Barinas-Mitchell, E
    Cushman, M
    Meilahn, EN
    Tracy, RP
    Kuller, LH
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : 1094 - 1101
  • [3] Bastard JP, 1999, CIRCULATION, V99, P2221
  • [4] Brull DJ, 2003, ATHEROSCLEROSIS, V168, P192
  • [5] Abdominal fat and insulin resistance in normal and overweight women - Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM
    Carey, DG
    Jenkins, AB
    Campbell, LV
    Freund, J
    Chisholm, DJ
    [J]. DIABETES, 1996, 45 (05) : 633 - 638
  • [6] C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites
    Chambers, JC
    Eda, S
    Bassett, P
    Karim, Y
    Thompson, SG
    Gallimore, JR
    Pepys, MB
    Kooner, JS
    [J]. CIRCULATION, 2001, 104 (02) : 145 - 150
  • [7] Pathogenesis of the insulin resistance syndrome (Syndrome X)
    Chisholm, DJ
    Campbell, LV
    Kraegen, EW
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (9-10): : 782 - 784
  • [8] Risk factors for coronary heart disease and acute-phase proteins - A population-based study
    Danesh, J
    Muir, J
    Wong, YK
    Ward, M
    Gallimore, JR
    Pepys, MB
    [J]. EUROPEAN HEART JOURNAL, 1999, 20 (13) : 954 - 959
  • [9] Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
    Danesh, J
    Whincup, P
    Walker, M
    Lennon, L
    Thomson, A
    Appleby, P
    Gallimore, JR
    Pepys, MB
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255): : 199 - 204
  • [10] New markers for cardiovascular disease risk in women: Impact of endogenous estrogen status and exogenous postmenopausal hormone therapy
    Davison, S
    Davis, SR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) : 2470 - 2478